✦ LIBER ✦

Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping

✍ Scribed by D. Frank; U. Jaehde; U. Fuhr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between fluvoxamine pharmac

✍ O. Spigset; K. Granberg; S. Hägg; Å. Norström; R. Dahlqvist 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

Drug extrapyramidal side effects. CYP2D6

✍ P. Vandel; E. Haffen; S. Vandel; B. Bonin; S. Nezelof; D. Sechter; F. Broly; P. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 134 KB

Phenotype and genotype analysis of debri

✍ C. Masimirembwa; J. Hasler; L. Bertilssons; I. Johansson; O. Ekberg; M. Ingelman 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 76 KB

Assessment of urinary mephenytoin metric

✍ Tobias Klaassen; Alexander Jetter; Dorota Tomalik-Scharte; Dirk Kasel; Julia Kir 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 236 KB

The pharmacokinetics of ketobemidone are

✍ Ayman Al-Shurbaji; Juliette Säwe 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 84 KB

An optimized methodology for combined ph

✍ Wim J. Tamminga; Johan Wemer; Berend Oosterhuis; Jan P.G. Brakenhoff; Mireille G 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 89 KB